Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
The purpose of this study is to compare pre and post Aromatase Inhibitor (AI) treatment serological markers of inflammation and assess for correlation with AI-MS.
Breast Cancer
OTHER: History and Physical Exam|OTHER: Grip Strength Measurement|BEHAVIORAL: Surveys|OTHER: Blood Collection|PROCEDURE: Ultrasound of Hand/Wrist
Presence, severity, and change in severity of pain based on joint exam and joint ultrasound inflammatory score., Study visits at 3, 6, 9 and 12 months after the start of treatment with an Aromatase Inhibitor
The purpose of this study is to compare pre and post Aromatase Inhibitor (AI) treatment serological markers of inflammation and assess for correlation with AI-MS.